NLS

While selecting a cancer treatment can be challenging, delivering it can be even more challenging. Not all molecules are readily absorbed by a cell and finding a way to plant treatments into the cell’s body can increase their effectiveness. That is where photochemical internalization (PCI) technology, an intracellular delivery method, comes in. Norwegian biopharmaceutical company […]

Since nothing is more basic to life than oxygen, Dr. Gregg Semenza, MD, PhD, found it logical to want to unravel some of the complexities of how cells monitor and regulate oxygen levels.

William Kaelin feels he has been fortunate in his scientific career. His contributions have had a great impact, not least within cancer treatment, and for future generations he emphasizes the importance of supporting basic science.

BioArctic’s lead compound has the potential to become the first disease-modifying treatment for Alzheimer’s, and so far the company’s journey has involved FDA approvals, a successful deal with AbbVie, collaborations with universities – and not least, the hiring of a very dedicated CEO. For years the treatments for central nervous system diseases such as Alzheimer’s […]

The development and use of biosimilars continues to grow in the Nordic countries, as well as the rest of Europe, and experts are excited about their potential. But there is a thicket of legal issues and regulations that companies have to navigate to get their drugs to the market. A biosimilar is almost identical to […]

Few companies are as synonymous with Sweden as AstraZeneca and few CEOs as visible. Yet, Katarina Ageborg, AstraZeneca Sweden’s new CEO, prefers not to think about being center stage, but instead about what her position can do for the company, Sweden and the pharmaceutical industry as a whole. “I don’t think about it that way […]